Furthermore, NOL7 protein expression was found to be significantly associated with disease progression in multiple cancers, including breast cancer, ovarian cancer, colon cancer, KIRC, HNSC, and LUAD (Supplementary Figure S3). This evidence concerns the gene NOL7 and ovarian carcinoma.